| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue, White | 12 | 2025 | 90 | 4.710 |
Why?
|
| Adipocytes, White | 7 | 2021 | 26 | 3.190 |
Why?
|
| MicroRNAs | 10 | 2025 | 951 | 2.730 |
Why?
|
| Energy Metabolism | 14 | 2024 | 809 | 2.630 |
Why?
|
| Insulin Resistance | 12 | 2025 | 685 | 2.380 |
Why?
|
| Adipocytes | 12 | 2025 | 160 | 2.380 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2021 | 41 | 1.700 |
Why?
|
| Obesity | 16 | 2025 | 2409 | 1.590 |
Why?
|
| Adipocytes, Brown | 3 | 2021 | 26 | 1.430 |
Why?
|
| Receptors, Androgen | 8 | 2018 | 433 | 1.370 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2023 | 426 | 1.290 |
Why?
|
| Glucose | 8 | 2025 | 923 | 1.280 |
Why?
|
| Adipogenesis | 6 | 2022 | 79 | 1.170 |
Why?
|
| STAT1 Transcription Factor | 4 | 2020 | 78 | 1.140 |
Why?
|
| Adipose Tissue | 6 | 2025 | 498 | 1.060 |
Why?
|
| Animals | 52 | 2025 | 36364 | 1.040 |
Why?
|
| Lipogenesis | 3 | 2025 | 58 | 1.040 |
Why?
|
| Homeostasis | 7 | 2024 | 751 | 1.030 |
Why?
|
| Growth Differentiation Factor 15 | 2 | 2025 | 29 | 1.010 |
Why?
|
| Lipid Metabolism | 6 | 2025 | 378 | 1.000 |
Why?
|
| Mice | 40 | 2025 | 18876 | 1.000 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 2657 | 0.990 |
Why?
|
| Signal Transduction | 14 | 2025 | 4893 | 0.980 |
Why?
|
| Body Temperature | 2 | 2025 | 130 | 0.970 |
Why?
|
| Adipose Tissue, Brown | 5 | 2021 | 78 | 0.970 |
Why?
|
| Acetyl Coenzyme A | 2 | 2025 | 14 | 0.950 |
Why?
|
| Body Temperature Regulation | 1 | 2025 | 50 | 0.950 |
Why?
|
| Aspartic Acid | 1 | 2025 | 84 | 0.940 |
Why?
|
| Postprandial Period | 1 | 2025 | 91 | 0.940 |
Why?
|
| PPAR gamma | 5 | 2020 | 86 | 0.900 |
Why?
|
| Mitochondria | 7 | 2023 | 741 | 0.840 |
Why?
|
| Electrolytes | 3 | 2007 | 55 | 0.820 |
Why?
|
| Reproduction | 2 | 2024 | 245 | 0.790 |
Why?
|
| Hyperinsulinism | 2 | 2021 | 71 | 0.740 |
Why?
|
| Microscopy | 2 | 2013 | 123 | 0.710 |
Why?
|
| Lipodystrophy | 1 | 2021 | 33 | 0.710 |
Why?
|
| Endocrine Disruptors | 2 | 2020 | 53 | 0.660 |
Why?
|
| Nanoparticles | 3 | 2007 | 284 | 0.650 |
Why?
|
| Paracrine Communication | 1 | 2020 | 74 | 0.650 |
Why?
|
| Panniculitis | 1 | 2019 | 19 | 0.650 |
Why?
|
| Inflammation | 5 | 2025 | 1595 | 0.640 |
Why?
|
| Subcutaneous Fat | 2 | 2024 | 34 | 0.640 |
Why?
|
| Phenols | 1 | 2019 | 57 | 0.630 |
Why?
|
| Mice, Knockout | 11 | 2025 | 3968 | 0.620 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 294 | 0.620 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 178 | 0.620 |
Why?
|
| Benzhydryl Compounds | 1 | 2019 | 68 | 0.610 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 623 | 0.610 |
Why?
|
| Immune System | 1 | 2019 | 98 | 0.600 |
Why?
|
| Metabolic Diseases | 2 | 2022 | 139 | 0.600 |
Why?
|
| Diet, High-Fat | 5 | 2025 | 231 | 0.600 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 150 | 0.590 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 366 | 0.590 |
Why?
|
| Gene Deletion | 2 | 2021 | 809 | 0.590 |
Why?
|
| Liver | 6 | 2024 | 1866 | 0.570 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 396 | 0.560 |
Why?
|
| Insulin | 3 | 2020 | 1246 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 1406 | 0.530 |
Why?
|
| HIV Infections | 3 | 2025 | 2066 | 0.510 |
Why?
|
| Cell Survival | 5 | 2020 | 890 | 0.460 |
Why?
|
| Humans | 53 | 2025 | 133809 | 0.450 |
Why?
|
| Endocytosis | 3 | 2009 | 132 | 0.450 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2010 | 256 | 0.430 |
Why?
|
| Fatty Liver | 3 | 2025 | 210 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 4799 | 0.410 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 2 | 2010 | 2 | 0.410 |
Why?
|
| Cells, Cultured | 9 | 2021 | 3165 | 0.410 |
Why?
|
| Orosomucoid | 2 | 2024 | 9 | 0.400 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2012 | 40 | 0.390 |
Why?
|
| Osteogenesis | 1 | 2013 | 167 | 0.380 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 479 | 0.370 |
Why?
|
| Fatty Acids | 2 | 2025 | 370 | 0.370 |
Why?
|
| Androgens | 2 | 2013 | 292 | 0.370 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2009 | 20 | 0.340 |
Why?
|
| RNA, Small Interfering | 7 | 2016 | 713 | 0.330 |
Why?
|
| Macrophages | 2 | 2025 | 701 | 0.330 |
Why?
|
| Drug Carriers | 2 | 2007 | 119 | 0.330 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 259 | 0.330 |
Why?
|
| Male | 27 | 2025 | 65830 | 0.330 |
Why?
|
| Polymers | 2 | 2007 | 121 | 0.330 |
Why?
|
| Biocompatible Materials | 2 | 2007 | 135 | 0.330 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 212 | 0.320 |
Why?
|
| Glucocorticoids | 1 | 2012 | 408 | 0.320 |
Why?
|
| Dynamin II | 1 | 2009 | 2 | 0.320 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2011 | 211 | 0.310 |
Why?
|
| Inflammasomes | 2 | 2021 | 164 | 0.310 |
Why?
|
| RNA Interference | 4 | 2020 | 542 | 0.310 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2011 | 351 | 0.300 |
Why?
|
| Software | 1 | 2013 | 737 | 0.280 |
Why?
|
| Interferon-gamma | 2 | 2020 | 538 | 0.280 |
Why?
|
| Computational Biology | 1 | 2013 | 888 | 0.280 |
Why?
|
| Female | 24 | 2025 | 71587 | 0.270 |
Why?
|
| 3T3-L1 Cells | 4 | 2020 | 55 | 0.270 |
Why?
|
| Colloids | 1 | 2007 | 17 | 0.270 |
Why?
|
| RNA, Messenger | 5 | 2022 | 2900 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 92 | 0.260 |
Why?
|
| Prostatic Neoplasms | 4 | 2018 | 1622 | 0.260 |
Why?
|
| Pyrimidines | 2 | 2025 | 417 | 0.250 |
Why?
|
| Lipase | 2 | 2025 | 98 | 0.250 |
Why?
|
| Chloroform | 1 | 2005 | 4 | 0.240 |
Why?
|
| Genetic Vectors | 2 | 2025 | 969 | 0.240 |
Why?
|
| Carrier Proteins | 4 | 2023 | 1065 | 0.240 |
Why?
|
| Mitochondria, Liver | 1 | 2005 | 34 | 0.240 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 308 | 0.240 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2025 | 53 | 0.230 |
Why?
|
| Cell Line | 5 | 2020 | 2837 | 0.230 |
Why?
|
| Viral Tropism | 1 | 2025 | 44 | 0.230 |
Why?
|
| Adipokines | 2 | 2024 | 72 | 0.220 |
Why?
|
| Membrane Potentials | 1 | 2005 | 317 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 1 | 2025 | 162 | 0.220 |
Why?
|
| Pharmacology, Clinical | 1 | 2023 | 5 | 0.210 |
Why?
|
| Hepatocytes | 1 | 2005 | 241 | 0.210 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 7 | 0.210 |
Why?
|
| Ovary | 2 | 2024 | 384 | 0.210 |
Why?
|
| HeLa Cells | 5 | 2013 | 827 | 0.210 |
Why?
|
| Flavoproteins | 1 | 2023 | 18 | 0.210 |
Why?
|
| Dependovirus | 1 | 2025 | 151 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2007 | 543 | 0.210 |
Why?
|
| Thermogenesis | 2 | 2021 | 48 | 0.210 |
Why?
|
| Sumoylation | 1 | 2023 | 38 | 0.210 |
Why?
|
| Receptors, Progesterone | 2 | 2018 | 896 | 0.210 |
Why?
|
| PPAR alpha | 1 | 2023 | 54 | 0.210 |
Why?
|
| Fibrosis | 1 | 2025 | 465 | 0.210 |
Why?
|
| Auranofin | 1 | 2022 | 3 | 0.200 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2023 | 124 | 0.200 |
Why?
|
| Mice, Obese | 1 | 2022 | 73 | 0.200 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2021 | 124 | 0.200 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2022 | 31 | 0.200 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2023 | 66 | 0.200 |
Why?
|
| Lipolysis | 2 | 2013 | 80 | 0.190 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 465 | 0.190 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2020 | 32 | 0.190 |
Why?
|
| High-Throughput Screening Assays | 2 | 2015 | 112 | 0.190 |
Why?
|
| Fasting | 1 | 2023 | 310 | 0.190 |
Why?
|
| Lung Injury | 1 | 2023 | 123 | 0.190 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 2760 | 0.190 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 13 | 0.180 |
Why?
|
| Hyperoxia | 1 | 2023 | 130 | 0.180 |
Why?
|
| Blotting, Western | 5 | 2020 | 1136 | 0.180 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 25 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2022 | 121 | 0.170 |
Why?
|
| CD11c Antigen | 1 | 2020 | 40 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2020 | 19 | 0.170 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 2011 | 27 | 0.170 |
Why?
|
| Kinetics | 3 | 2007 | 1354 | 0.170 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2023 | 212 | 0.170 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2020 | 1 | 0.170 |
Why?
|
| Pancreatic Polypeptide | 1 | 2020 | 7 | 0.170 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2020 | 4 | 0.170 |
Why?
|
| Dynamins | 1 | 2020 | 43 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2020 | 122 | 0.170 |
Why?
|
| Glycogen | 1 | 2020 | 66 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2020 | 22 | 0.170 |
Why?
|
| Somatostatin | 1 | 2020 | 69 | 0.160 |
Why?
|
| Autophagy | 2 | 2020 | 420 | 0.160 |
Why?
|
| Ghrelin | 1 | 2020 | 53 | 0.160 |
Why?
|
| Lipid Droplets | 1 | 2020 | 48 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 74 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 1069 | 0.160 |
Why?
|
| Hepatitis | 1 | 2020 | 58 | 0.160 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 22 | 0.160 |
Why?
|
| Patched-1 Receptor | 1 | 2019 | 50 | 0.160 |
Why?
|
| Blood Glucose | 2 | 2021 | 1195 | 0.160 |
Why?
|
| Pituitary Gland | 1 | 2019 | 88 | 0.150 |
Why?
|
| Cell Line, Tumor | 9 | 2018 | 3748 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 228 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 395 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 39 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2018 | 197 | 0.150 |
Why?
|
| Flow Cytometry | 4 | 2020 | 836 | 0.150 |
Why?
|
| Transgenes | 2 | 2025 | 346 | 0.150 |
Why?
|
| Integrases | 1 | 2019 | 163 | 0.150 |
Why?
|
| Body Composition | 1 | 2021 | 564 | 0.140 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 30 | 0.140 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 522 | 0.140 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 73 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 106 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2018 | 77 | 0.140 |
Why?
|
| Solubility | 2 | 2007 | 144 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 610 | 0.130 |
Why?
|
| Protein Isoforms | 3 | 2020 | 429 | 0.130 |
Why?
|
| HEK293 Cells | 4 | 2022 | 812 | 0.130 |
Why?
|
| Precision Medicine | 2 | 2011 | 356 | 0.130 |
Why?
|
| Metabolomics | 1 | 2020 | 456 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 217 | 0.130 |
Why?
|
| Argonaute Proteins | 1 | 2016 | 31 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 234 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 4769 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 62 | 0.130 |
Why?
|
| Water | 2 | 2007 | 198 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2014 | 2026 | 0.120 |
Why?
|
| Cell Proliferation | 6 | 2016 | 2539 | 0.120 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 87 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 522 | 0.120 |
Why?
|
| Hypogonadism | 1 | 2019 | 311 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 506 | 0.120 |
Why?
|
| Protein Binding | 3 | 2018 | 1834 | 0.120 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 1757 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 85 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 823 | 0.110 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1076 | 0.110 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 39 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 3057 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 207 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 501 | 0.110 |
Why?
|
| Mutation | 4 | 2014 | 6292 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 8 | 0.110 |
Why?
|
| Citric Acid Cycle | 1 | 2014 | 50 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 290 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 76 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 338 | 0.110 |
Why?
|
| NAD | 1 | 2014 | 46 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 351 | 0.110 |
Why?
|
| Glycolysis | 1 | 2014 | 169 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 406 | 0.110 |
Why?
|
| Uveal Neoplasms | 1 | 2014 | 61 | 0.110 |
Why?
|
| Metribolone | 1 | 2013 | 31 | 0.100 |
Why?
|
| Testosterone Congeners | 1 | 2013 | 19 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 85 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2014 | 317 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2014 | 244 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2013 | 1702 | 0.100 |
Why?
|
| Lentivirus | 1 | 2013 | 86 | 0.100 |
Why?
|
| Support Vector Machine | 1 | 2012 | 22 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2014 | 304 | 0.100 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 71 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2010 | 73 | 0.100 |
Why?
|
| Reactive Oxygen Species | 3 | 2023 | 525 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 666 | 0.100 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 34 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 184 | 0.090 |
Why?
|
| Fertility | 1 | 2014 | 267 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2013 | 164 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 128 | 0.090 |
Why?
|
| Ligands | 2 | 2023 | 572 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 884 | 0.090 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2011 | 39 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2023 | 2703 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 612 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2011 | 15 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2082 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2014 | 490 | 0.090 |
Why?
|
| Cell Surface Extensions | 1 | 2010 | 7 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 262 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2013 | 454 | 0.080 |
Why?
|
| Arginine | 1 | 2013 | 349 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 862 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 1718 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 464 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 382 | 0.080 |
Why?
|
| Biomarkers | 2 | 2025 | 3423 | 0.080 |
Why?
|
| Internet | 1 | 2013 | 401 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2011 | 394 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1070 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 438 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 508 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 292 | 0.080 |
Why?
|
| Myoblasts | 1 | 2009 | 36 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 2123 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 547 | 0.080 |
Why?
|
| Thiazoles | 1 | 2009 | 102 | 0.080 |
Why?
|
| Rats | 2 | 2020 | 3878 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 136 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 395 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2009 | 301 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 2161 | 0.070 |
Why?
|
| Drug Compounding | 1 | 2007 | 43 | 0.070 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 56 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2014 | 39 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 1326 | 0.070 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 122 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 145 | 0.070 |
Why?
|
| Chemistry, Physical | 1 | 2007 | 31 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 486 | 0.070 |
Why?
|
| Ions | 1 | 2007 | 24 | 0.070 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 182 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 137 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 152 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2007 | 388 | 0.070 |
Why?
|
| Melanoma | 1 | 2014 | 974 | 0.060 |
Why?
|
| Transcriptome | 1 | 2013 | 1126 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 469 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 365 | 0.060 |
Why?
|
| Rhodamine 123 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cattle | 2 | 2020 | 588 | 0.060 |
Why?
|
| Progesterone | 2 | 2018 | 630 | 0.060 |
Why?
|
| Serogroup | 1 | 2025 | 63 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2005 | 167 | 0.060 |
Why?
|
| Phenotype | 2 | 2012 | 4530 | 0.060 |
Why?
|
| Cell Movement | 3 | 2016 | 917 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2025 | 403 | 0.060 |
Why?
|
| Biological Transport | 2 | 2018 | 370 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2025 | 296 | 0.050 |
Why?
|
| Apoptosis | 2 | 2014 | 1931 | 0.050 |
Why?
|
| Zygote | 1 | 2023 | 31 | 0.050 |
Why?
|
| Antifoaming Agents | 1 | 2003 | 2 | 0.050 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 1 | 2022 | 14 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 861 | 0.050 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2025 | 140 | 0.050 |
Why?
|
| Egg Proteins | 1 | 2003 | 55 | 0.050 |
Why?
|
| Lidocaine | 1 | 2003 | 50 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2003 | 321 | 0.050 |
Why?
|
| Ovarian Follicle | 1 | 2023 | 123 | 0.050 |
Why?
|
| Triglycerides | 1 | 2025 | 613 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 277 | 0.050 |
Why?
|
| Proteins | 1 | 2007 | 1087 | 0.050 |
Why?
|
| Transfection | 2 | 2016 | 1088 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2013 | 170 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 1353 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2020 | 921 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2529 | 0.050 |
Why?
|
| Serotonin | 1 | 2022 | 225 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Oocytes | 1 | 2023 | 302 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 42 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 433 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2020 | 48 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 160 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 392 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 84 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2020 | 123 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 68 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2025 | 733 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2023 | 1045 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 446 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2020 | 54 | 0.040 |
Why?
|
| Adult | 4 | 2025 | 31928 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 56 | 0.040 |
Why?
|
| src-Family Kinases | 2 | 2010 | 98 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 49 | 0.040 |
Why?
|
| Sex Factors | 1 | 2023 | 1384 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 133 | 0.040 |
Why?
|
| Disease Progression | 2 | 2018 | 2240 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 195 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 66 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 39 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 243 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 62 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 103 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 177 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 90 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2018 | 133 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 64 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 317 | 0.040 |
Why?
|
| Neoplasms | 1 | 2013 | 3023 | 0.030 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 98 | 0.030 |
Why?
|
| Glutamine | 1 | 2018 | 222 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 218 | 0.030 |
Why?
|
| Testis | 1 | 2019 | 426 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 271 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1764 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3064 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2016 | 42 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 592 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1676 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 724 | 0.030 |
Why?
|
| Estrogens | 1 | 2018 | 522 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1555 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 435 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 581 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 49 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 774 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 20 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 17 | 0.030 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 55 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2014 | 24 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2014 | 43 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2018 | 834 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 88 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 34 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1153 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 595 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 172 | 0.030 |
Why?
|
| Decidua | 1 | 2014 | 142 | 0.030 |
Why?
|
| Perilipin-1 | 1 | 2013 | 7 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 29350 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 201 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 315 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 193 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 644 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2301 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1136 | 0.020 |
Why?
|
| Castration | 1 | 2012 | 33 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2013 | 206 | 0.020 |
Why?
|
| Chromones | 1 | 2012 | 26 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 271 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 201 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1872 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 51 | 0.020 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2012 | 4 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 95 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 64 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 182 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 323 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 627 | 0.020 |
Why?
|
| Endometriosis | 1 | 2014 | 184 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 590 | 0.020 |
Why?
|
| Glycolipids | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2012 | 262 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 609 | 0.020 |
Why?
|
| Gelatin | 1 | 2010 | 17 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 32 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 866 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1535 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 619 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2014 | 559 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 260 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 158 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1307 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 204 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2011 | 472 | 0.020 |
Why?
|
| Transferrin | 1 | 2009 | 50 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 486 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2009 | 222 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 363 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2013 | 364 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 400 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2009 | 153 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 69 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 118 | 0.020 |
Why?
|
| Dasatinib | 1 | 2009 | 50 | 0.020 |
Why?
|
| Tubulin | 1 | 2009 | 76 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1102 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 110 | 0.020 |
Why?
|
| G1 Phase | 1 | 2009 | 67 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1614 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2009 | 239 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 775 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 387 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2011 | 374 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 412 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2009 | 177 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 790 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 272 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 783 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 352 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 687 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1735 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1912 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 1621 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 5068 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 11071 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2935 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 2807 | 0.010 |
Why?
|
| Surface Tension | 1 | 2003 | 6 | 0.010 |
Why?
|
| Drug Stability | 1 | 2003 | 62 | 0.010 |
Why?
|
| Child | 1 | 2022 | 25743 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7513 | 0.010 |
Why?
|